Covidien agrees to settle some cases over transvaginal mesh devices

NEW YORK, June 24 (Reuters) - Medtronic Plc's Covidien unit has agreed to settle some of the more than 11,000 claims involving its transvaginal mesh devices, which patients allege caused severe and painful side effects, according to a court filing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.